Results 91 to 100 of about 5,275 (178)

Atrial Fibrillation Risk and Urate-Lowering Therapy in Patients with Gout: A Cohort Study Using a Clinical Database. [PDF]

Biomedicines, 2022
Liu CH, Huang SC, Yin CH, Huang WC, Chen JS, Chen YS, Gan ST, Tzou SJ, Hsu CT, Wu HM, Wang WH.   +10 more
europepmc   +1 more source

The Effect of Decrease in Serum Urate for the Risk of Gout Flares During Urate-Lowering Therapy Initiation Among Chinese Male Gout Patients: A Prospective Cohort Study. [PDF]

J Inflamm Res, 2023
Pang L, Xue X, He Y, Wang C, Han L, Li M, Qi H, Li C, Lu J.   +8 more
europepmc   +1 more source

Early urate-lowering therapy in gouty arthritis with acute flares: a double-blind placebo controlled clinical trial. [PDF]

Eur J Med Res, 2023
Yang DH, Chen HC, Wei JC.
europepmc   +1 more source

Monitoring and Achievement of Target Serum Urate Among Gout Patients Receiving Long-Term Urate-Lowering Therapy in the American College of Rheumatology RISE Registry. [PDF]

Arthritis Care Res (Hoboken), 2023
Hammam N, Li J, Kay J, Izadi Z, Yazdany J, Schmajuk G.   +5 more
europepmc   +1 more source

Urate-lowering therapy and kidney outcomes in patients with chronic kidney disease and hyperuricemia. [PDF]

Signal Transduct Target Ther
Nie S, Zhou S, Chen R, Li L, Sun Y, Liu J, Jin L, Shao X, Pang M, Su L, Luo F, Xu X, Hou FF.   +12 more
europepmc   +1 more source

Safety of colchicine and NSAID prophylaxis when initiating urate-lowering therapy for gout: propensity score-matched cohort studies in the UK Clinical Practice Research Datalink. [PDF]

Ann Rheum Dis, 2023
Roddy E, Bajpai R, Forrester H, Partington RJ, Mallen CD, Clarson LE, Padmanabhan N, Whittle R, Muller S.   +8 more
europepmc   +1 more source

Development of a patient decision aid for the initiation of urate-lowering therapy in gout patients. [PDF]

RMD Open, 2022
Te Kampe R, Boonen A, Jansen T, Janssen M, de Vries H, van Durme C.   +5 more
europepmc   +1 more source

Caring for Australians and New Zealanders With Kidney Impairment Guidelines: Rapid Development of Urate Lowering Therapy Guidelines for People With CKD. [PDF]

Kidney Int Rep, 2022
Stanley IK, Phoon RKS, Toussaint ND, Cullen V, Kearns J, Dalbeth N, Johnson DW, Krishnasamy R, Tunnicliffe DJ, CARI Guidelines Steering Committee.   +9 more
europepmc   +1 more source

I83. Population Use of Urate-Lowering Therapy [PDF]

Rheumatology, 2015
openaire   +1 more source

Improvements in Health-Related Quality of Life With Treat-to-Target Urate-Lowering Therapy in Gout: A Post Hoc Analysis of a Randomized Multicenter Trial. [PDF]

Arthritis Care Res (Hoboken)
Barry A, England BR, Sayles H, Helget LN, Androsenko M, Wu H, Michaud K, Kramer B, Newcomb JA, Brophy MT, Davis-Karim A, Ferguson R, Pillinger MH, Neogi T, Palevsky PM, O'Dell JR, Mikuls TR.   +16 more
europepmc   +1 more source